Examine the global pharmaceutical industry and the effect of national, regulatory, economic, and market environments on the competitiveness of the industry! This unique book is the only empirical study that examines the effects of the national environment on the competitiveness of a country's pharmaceutical industry. This informative book explores such topics as the types of comparative advantages that firms use for developing competitive advantages and what strategic choices firms should make when collaborating with international firms. Public policy implications with respect to the economic environment are also discussed to give you a complete look at the international pharmaceutical industry. Global Competitiveness in the Pharmaceutical Industry recognizes pharmaceutical industries as being of great social and public importance to all countries, since so many life saving drugs have emerged from pharmaceutical laboratories over the past four decades. By helping to combat many fatal diseases and eradicate others, drug producers have helped to positively alter mortality patterns in many parts of the world, thus making companies compete to provide many important medicines. The unique research presented in this book examines the determinants of global competitive advantage in the pharmaceutical industry by answering such questions as: Which factors stimulate or inhibit a nation's pharmaceutical industry to be globally innovative? Which factors stimulate or inhibit diffusion of pharmaceutical innovations (NECs) into its markets? Are there differences between industrialized and developing countries with respect to factors that affect innovation and global competitiveness in the pharmaceutical industry? Global Competitiveness in the Pharmaceutical Industry makes several theoretical, empirical, and methodological contributions which lead to results and generate important managerial and public policy implications. You will find a comprehensive overview of the nature of global competition in the pharmaceutical industry and its evolution in the post World War II period. Global Competitiveness in the Pharmaceutical Industry provides you with an in-depth understanding of the dynamics and importance of the global pharmaceutical market.

In terms of overall orientation, this book has been so conceived and structured that it has followed a certain natural corollary and logical framework in comparing Indian economy with the Asian and the global economy in respect to the sectors wherein India is perceived to play a leadership role both in the regional and the global context. Secondly, an attempt has also been made to identify areas, where, India, despite possessing a huge potential, could not so far convincingly demonstrate its competitive advantage to compete globally. Thirdly, competitive advantages in certain chosen fields, wherein India can excel and outperform its competitors are elaborated and highlighted with broad indication of the future strategy. Last, but not the least, the book has dealt with the various sectoral investment opportunities in India for achieving global competitiveness.

The process of development in recent times has been characteristically marked by the expanding reach of multinational enterprises, flows of foreign direct investment, unprecedented growth of information and communication technologies (ICT) and knowledge-based industries, and infusion of ICT across the entire spectrum of industries and activities. High-tech knowledge-based industries like information technology, biotechnology, pharmaceuticals and so on have played an important role in the transition of Chinese and Indian economies—the two largest and fastest growing economies. This inter-disciplinary book offers an in-depth understanding of the behaviour of firms in these industries, analysing the strategies they adopt in a globally competitive environment, the role they have played in ushering in the growth revolution in China and India, and the contribution they have made to the nature and growth of employment. This study also dwells upon the emerging nature of scientific and technological developments like nanotechnology, novel materials, spintronics and quantum computers, with the conclusion that in the future, knowledge and technology are going to be the real sources of wealth for nations.

Die Globalisierung der Märkte zwingt Europa nicht nur zu einer intensiven Auseinandersetzung mit den daraus erwachsenden Problemen, sondern auch zur Ausgestaltung geeigneter Wettbewerbsstrategien, um im Kampf um Marktvorteile bestehen zu können. Namhafte Experten aus Wissenschaft und Praxis analysieren in diesem Buch Stärken und Schwächen der Europäischen Union und diskutieren ihre Rolle im globalen Wettbewerb aus unterschiedlichen Blickrichtungen. Es werden u.a. folgende Themen behandelt: - Europa im globalen Wettbewerb - Interkulturelles Management zwischen Universalismus und Relativismus - Das Konzept der Marktwirtschaft und das Prinzip der Gemeinschaft (

In the post-liberalization period, India has slowly but steadily tried to foster innovation to improve competitive efficiency of Indian manufacturing and thus boost global competitiveness of the industrial sector. Foreign direct investment was looked upon as a major source of technology paradigm shift; in recent times, industrial firms have been investing overseas, even in countries to which they used to export, based on their technological capabilities. Firms in Indian manufacturing industries have also attempted to bring about technological upgrades through imports of design and drawings (disembodied technology) against lump sum, royalty and technical knowhow fees, and imports of capital machinery (embodied technology) where the technology is embodied in the capital good itself. This volume comprises empirical contributions on this emerging phenomenon, on a range of issues including the role of R&D; mergers, acquisitions and technological efforts; technological determinants of competitive advantages; the role of small and medium enterprises and regional patterns; technological efforts and global operations; and the role of industrial clusters in promoting innovation and competitiveness. This book was originally published as a special issue of Innovation and Development.

Twenty-one authors from a variety of backgrounds analyse the global competitiveness of the Asian firm in different parts of the world and at different phases of their internationalisation process. They find that the Asian firms' emphasis on 'soft' skills such as networking, organisational learning and sharing stands in sharp contrast to the economic rationality of Western firms, which stress individual performance measurement, clearly defined responsibilities and accountability. Asian firms face serious problems in adjusting their systems to the Western environment without losing their competitiveness.

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.